Juno Therapeutics Receives $120,000,000 Series A Financing Round

  • Feed Type
  • Date
    12/5/2013
  • Company Name
    Juno Therapeutics
  • Mailing Address
    307 Westlake Avenue North Seattle, WA 98109
  • Company Description
    Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
  • Website
    http://www.junotherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $120,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Alaska Permanent Fund
  • Venture Investor
    Undisclosed